2026-08-20Bearish
-5.08%24 hours changeSector-wide MedTech selling triggered technical profit-taking following consecutive guidance cuts and slowing U.S. growth engines.
read the report →Boston Scientific Corporation is a global leader in less-invasive medical technology, operating across Cardiovascular and MedSurg segments.
Sector-wide MedTech selling triggered technical profit-taking following consecutive guidance cuts and slowing U.S. growth engines.
read the report →